The Association of Cytokines with Severe Dengue in Children
暂无分享,去创建一个
Nguyen Tien Huy | Nguyen Thi Phuong Lan | T. T. Thuy | K. Hirayama | Kenji Hirayama | Tran Thi Ngoc Ha | Tran Thi Thuy | Ha Manh Tuan | Cao Thi Phi Nga | Vo Van Tuong | Tran Van Dat | Vu Thi Que Huong | N. Huy | Julia N.A. Mangione | Evaristus Chibunna Mbanefo | Lam Quoc Bao | Trần Thị Ngọc Hà | N. T. Lan | H. M. Tuan | V. Huong | J. Mangione | E. Mbanefo | L. Bao | V. Tuong
[1] S. Green,et al. Markers of dengue disease severity. , 2010, Current topics in microbiology and immunology.
[2] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[3] A. Nisalak,et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. , 1991, The Journal of clinical investigation.
[4] Yee‐Shin Lin,et al. Correlation of IFN-inducible protein 10 levels in Sera with disease severity and clinical outcome of the dengue patients , 2008 .
[5] K. Schroder,et al. Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.
[6] A. Rothman,et al. Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue. , 2005, Cytokine.
[7] T. Hien,et al. Factors Associated with Dengue Shock Syndrome: A Systematic Review and Meta-Analysis , 2013, PLoS neglected tropical diseases.
[8] S. Kalayanarooj,et al. Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever , 2006, Journal of Virology.
[9] Bill Bynum,et al. Lancet , 2015, The Lancet.
[10] K. Morita,et al. Association of Mast Cell-Derived VEGF and Proteases in Dengue Shock Syndrome , 2012, PLoS neglected tropical diseases.
[11] S. Yoksan,et al. Alteration of Cytokines and Chemokines During Febrile Episodes Associated With Endothelial Cell Damage and Plasma Leakage in Dengue Hemorrhagic Fever , 2012, The Pediatric infectious disease journal.
[12] S. Kapoor,et al. Elevated levels of IL‐8 in dengue hemorrhagic fever , 1998, Journal of medical virology.
[13] Rosanna W. Peeling,et al. Dengue: a continuing global threat , 2010, Nature Reviews Microbiology.
[14] Y. S. Lin,et al. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. , 2000, The American journal of tropical medicine and hygiene.
[15] M. Juffrie,et al. Inflammatory Mediators in Dengue Virus Infection: Circulating Interleukin-12 and Interferon-? , 2002 .
[16] E. Azeredo,et al. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. , 2001, Immunobiology.
[17] A. Rothman,et al. Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. , 2006, Endothelium : journal of endothelial cell research.
[18] J. V. D. van der Meer,et al. Cytokine patterns during dengue shock syndrome. , 2003, European cytokine network.
[19] B. Murgue,et al. Plasma concentrations of sVCAM‐1 and severity of dengue infections , 2001, Journal of medical virology.
[20] M. Guzmán,et al. Apoptosis in tissues from fatal dengue shock syndrome. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[21] Y. Chan,et al. Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[22] E L Braga,et al. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. , 2001, Memorias do Instituto Oswaldo Cruz.
[23] Y. Poovorawan,et al. The role of vascular endothelial growth factor leading to vascular leakage in children with dengue virus infection , 2007, Annals of tropical paediatrics.
[24] Fernando A Bozza,et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity , 2008, BMC infectious diseases.
[25] T Kadhiravan,et al. Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[26] A. Nisalak,et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. , 1989, The American journal of tropical medicine and hygiene.
[27] A. Osterhaus,et al. Elevation of soluble VCAM‐1 plasma levels in children with acute dengue virus infection of varying severity , 2004, Journal of medical virology.
[28] Albert D. M. E. Osterhaus,et al. Dengue Virus Pathogenesis: an Integrated View , 2009, Clinical Microbiology Reviews.
[29] G. Kuno,et al. Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. , 1984, The American journal of tropical medicine and hygiene.
[30] S. Kapoor,et al. SHIFT FROM A TH1-TYPE RESPONSE TO TH2-TYPE IN DENGUE HAEMORRHAGIC FEVER , 1999 .
[31] R. Lanciotti,et al. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction , 1992, Journal of clinical microbiology.
[32] S. Inoue,et al. Isolation and characterization of two phenotypically distinct dengue type-2 virus isolates from the same dengue hemorrhagic Fever patient. , 2009, Japanese journal of infectious diseases.
[33] 日本熱帯医学会. Tropical medicine and health , 2004 .
[34] D. Gubler,et al. Update on Dengue: Epidemiology, Virus Evolution, Antiviral Drugs, and Vaccine Development , 2010, Current infectious disease reports.
[35] A. Rothman,et al. Increased Production of Interleukin-8 in Primary Human Monocytes and in Human Epithelial and Endothelial Cell Lines after Dengue Virus Challenge , 2002, Journal of Virology.
[36] C. Ker,et al. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. , 2005, FEMS immunology and medical microbiology.
[37] A. Nisalak,et al. Elevated plasma interleukin‐10 levels in acute dengue correlate with disease severity , 1999, Journal of medical virology.
[38] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[39] A. Mustafa,et al. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. , 2000, FEMS immunology and medical microbiology.
[40] B. Wu-Hsieh,et al. Enhancement by Tumor Necrosis Factor Alpha of Dengue Virus-Induced Endothelial Cell Production of Reactive Nitrogen and Oxygen Species Is Key to Hemorrhage Development , 2008, Journal of Virology.
[41] K. Schroder,et al. Interferon- : an overview of signals, mechanisms and functions , 2004 .
[42] S. Halstead,et al. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. , 2004, The Journal of infectious diseases.
[43] A. Nisalak,et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. , 1999, The Journal of infectious diseases.
[44] Trai-Ming Yeh,et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. , 2006, The American journal of tropical medicine and hygiene.
[45] B. Seliger,et al. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. , 1998, Journal of immunology.